Dunaieva, I.P. 2025. “Liraglutide As a Means of Modifying Cardiometabolic Risk in Patients With Arterial Hypertension and Concomitant Obesity”. Inter Collegas 12 (2). https://doi.org/10.35339/ic.2025.12.2.dun.